MyPillow
TINA.org investigated My Pillow, a Minnesota company that has sold millions of foam-filled bed pillows across the country, and found that the company was making deceptive and unsubstantiated disease-treatment claims…
MyPillow’s Marketing
August 2016: The named-plaintiffs voluntarily dismissed this action When a complaint is dismissed with prejudice, it cannot be refiled.. The reasons for the dismissal have not been disclosed.
March 2016: A false advertising class-action lawsuit was filed against MyPillow. Specifically, the complaint claims that the company deceptively places the logos of news reporting entities on its website to make consumers think that these organizations endorse MyPillow when they do not. In addition, plaintiffs allege that the marketing deceptively represents that MyPillow’s CEO and inventor is a “sleep expert” when such claims are not true. (Kadkhoda et al v. My Pillow, Inc., Case No. 16-cv-2216, C. D. CA.)
For more information about the marketing of MyPillow and TINA.org’s coverage of the company, click here.
Legal Action
Class-Action Tracker
MyPillow’s Buy One Get One Free Offer
May 2018: This case was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.. August 2017: This action was stayed pending a settlement in a related…
MyPillow’s BOGO and 50% Off Claims
May 2018: Both cases were dismissed because they were resolved as part of the nationwide settlement in Amiri v. MyPillow. Click on the links below to see the filings in…
MyPillow’s BOGO Codes
December 2017: The company asked the Court to temporarily stay the case pending final approval of a related nationwide settlement in a California case, Amiri v. My Pillow. October 2017:…
MyPillow’s Marketing Claims
September 2017: A state court judge preliminarily approved a revised settlement agreement. According to the terms of the revised agreement, class members who purchased pillows directly from MyPillow may receive…
The Latest
The Cost of Doing Business
Comparing the amount companies agree to pay to settle deceptive marketing charges with their annual revenue.
Drug Pitched to Trump for Covid-19 Comes From a Deadly Plant
Heather Murphy, New York Times
Five Reasons the BBB Shouldn’t Be Your Only Stop
Researching a company shouldn’t be one-stop shopping.
Cure or Con? Health products touted on social media are slipping by regulators
Emile Le Beau Lucchesi, ABA Journal
5 Ad Trends to Be Wary of in 2020
CGI influencers are here.